Today: 28 June 2026
Prudential share price slips again as buyback rolls on; March results now in focus
24 February 2026
1 min read

Prudential share price slips again as buyback rolls on; March results now in focus

London, Feb 24, 2026, 09:16 GMT — Regular session

  • Shares of Prudential dropped about 0.8% at the open in London.
  • The insurer announced another round of share repurchases as part of its ongoing 2026 buyback programme.
  • Investors are watching for the group’s full-year results, expected mid-March.

Prudential shares opened lower Tuesday, extending losses from Monday as investors weighed fresh information on the insurer’s ongoing share buyback plan.

The stock last traded at 1,109 pence, down 8.5 pence from Monday’s close. In today’s action, shares moved between 1,100.5p and 1,120.0p.

Prudential’s been scooping up sizable chunks of its own stock, yet the market’s barely blinking. With full-year results due in a few weeks, even the smallest signals on cash flow or capital returns are grabbing disproportionate notice.

Prudential snapped up 335,080 shares on Feb. 23, shelling out an average of 11.3801 pounds apiece. The insurer intends to cancel these shares, which will bring its outstanding total down to 2,536,577,427.

Companies executing share buybacks pull their own stock off the market, typically to trim share count and bolster figures such as earnings per share. Traders pay close attention to the price levels where buybacks happen, plus the daily pace of those repurchases.

Prudential has launched a $1.2 billion buyback, handing the reins to J.P. Morgan Securities and targeting a finish date of Dec. 18, 2026. CEO Anil Wadhwani, announcing the move, highlighted a commitment to “consistent delivery of shareholder returns.” prudentialplc.com

The company flagged uncertainty around timing and pace for returns, tying them directly to market conditions—no guarantees that the program will be completed in full. That’s the catch: buybacks could slow down or go missing altogether, just as markets might be counting on them.

Prudential shares slipped 1.37% to close at 11.18 pounds on Monday, falling behind the mostly flat FTSE 100.

Prudential’s shares tend to move with changes in risk appetite or policy shifts in its main markets across Asia and Africa—UK investor flows aren’t the only driver. Its business spans life and health insurance, along with asset management, in both regions.

Up next for the company: 2025 full-year results, slated for March 18 in Hong Kong, per Prudential’s financial calendar.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Globus Medical (GMED) Stock Posts 47% Gain, Valuation Indicates Further Upside
    June 27, 2026, 10:51 PM EDT. Globus Medical (GMED) shares have surged 47.2% over the past year, driven by its role in the medical devices sector. Despite recent price fluctuations, the stock trades at around $86.25, significantly below its intrinsic value. A Discounted Cash Flow (DCF) analysis values the stock at approximately $160.09 per share, indicating it is undervalued by about 46%. The DCF model projects growing free cash flows, rising from $620.8 million last year to over $1.2 billion by 2035. This suggests the current market price offers potential upside for investors, supported by a 6/6 value score from Simply Wall St. Investors should consider these valuation metrics in the context of industry trends and long-term growth prospects before making investment decisions.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop